December 11th, 2017
jobs
homes

Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Globus Medical, Inc. Class A Common Stock (NY:GMED)

93.47 -0.42 (-0.45%)
Official Closing Price Updated: 7:00 PM EST, Jan 16, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Globus Medical, Inc. Class A Common Stock

< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
News headline image
GLOBUS MEDICAL INC - A (NYSE:GMED) – A Strong Growth Stock with Technical Breakout Potential ↗
Globus Medical (NYSE:GMED) shows strong growth fundamentals and a technical setup suggesting a potential breakout. The stock combines revenue growth, profitability, and a favorable chart pattern. 
Via Chartmill
News headline image
GLOBUS MEDICAL INC - A (NYSE:GMED) - A Strong Growth Stock with Reasonable Valuation ↗
GLOBUS MEDICAL (NYSE:GMED) is a strong growth stock with reasonable valuation, solid profitability, and a healthy balance sheet, making it an attractive option for investors seeking growth at a fair... 
Via Chartmill
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc. - GMED
From Pomerantz LLP
Via GlobeNewswire
News headline image
2 Growth Stocks to Add to Your Roster and 1 to Brush Off
Growth is oxygen. But when it evaporates, the consequences can be extreme - ask anyone who bought Cisco in the Dot-Com Bubble (Nvidia?) or newer investors who lived through the 2020 to 2022 COVID... 
Via StockStory
News headline image
A Look Into Globus Medical Inc's Price Over Earnings ↗
 
Via Benzinga
News headline image
Earnings Scheduled For May 8, 2025 ↗
 
Via Benzinga
News headline image
What Does the Market Think About Globus Medical? ↗
 
Via Benzinga
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Globus Medical, Inc. – GMED
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc.  - GMED
From Pomerantz LLP
Via GlobeNewswire
News headline image
This Commercial Metals Analyst Turns Bullish; Here Are Top 5 Upgrades For Tuesday ↗
 
Via Benzinga
News headline image
This United States Steel Analyst Is No Longer Bullish; Here Are Top 3 Downgrades For Tuesday ↗
 
Via Benzinga
News headline image
Assessing Globus Medical: Insights From 4 Financial Analysts ↗
 
Via Benzinga
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc. - GMED
From Pomerantz LLP
Via GlobeNewswire
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Globus Medical, Inc.  - GMED
From Pomerantz LLP
Via GlobeNewswire
News headline image
Globus Medical Announces $500 Million Share Repurchase Program
From Globus Medical
Via GlobeNewswire
News headline image
GLOBUS MEDICAL INC - A (NYSE:GMED) - A Strong Growth Stock at a Reasonable Price ↗
GLOBUS MEDICAL (NYSE:GMED) offers strong growth potential at a reasonable valuation, backed by solid financial health. A closer look at its fundamentals suggests it could be a compelling pick for... 
Via Chartmill
News headline image
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Globus Medical, Inc. – GMED
From Pomerantz LLP
Via GlobeNewswire
News headline image
Solventum, Envista, ICU Medical, Globus Medical, and Enovis Stocks Trade Up, What You Need To Know
A number of stocks jumped in the afternoon session after the major indices popped (Nasdaq +3.4%, S&P 500 +2.5%) in response to the positive outcome of U.S.-China trade negotiations, as both sides... 
Via StockStory
Topics Government Stocks World Trade
News headline image
A Glimpse Into The Expert Outlook On Globus Medical Through 6 Analysts ↗
 
Via Benzinga
News headline image
Expedia, Wolfspeed, HubSpot And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why Pinterest Shares Are Trading Higher By 13%; Here Are 20 Stocks Moving Premarket ↗
 
Via Benzinga
News headline image
Curious about the stocks that are showing activity after the closing bell on Thursday? ↗
Let's have a look at what is happening on the US markets after the closing bell on Thursday. Below you can find the top gainers and losers in today's after hours session. 
Via Chartmill
News headline image
12 Health Care Stocks Moving In Thursday's After-Market Session ↗
 
Via Benzinga
News headline image
Globus Medical (NYSE:GMED) Reports Sales Below Analyst Estimates In Q1 Earnings, Stock Drops 17.1%
Medical device company Globus Medical (NYSE:GMED) missed Wall Street’s revenue expectations in Q1 CY2025, with sales falling 1.4% year on year to $598.1 million. On the other hand, the company’s... 
Via StockStory
News headline image
Globus Medical Reports First Quarter 2025 Results
From Globus Medical
Via GlobeNewswire
News headline image
Earnings To Watch: Globus Medical (GMED) Reports Q1 Results Tomorrow
Medical device company Globus Medical (NYSE:GMED) will be announcing earnings results tomorrow after market close. Here’s what to look for. 
Via StockStory
News headline image
GLOBUS MEDICAL INC - A (NYSE:GMED) ↗
Globus Medical (NYSE:GMED) shows strong growth potential with solid fundamentals and a promising technical setup, making it a stock to watch for investors seeking high-growth opportunities. 
Via Chartmill
News headline image
Globus Medical (GMED): Buy, Sell, or Hold Post Q4 Earnings?
Globus Medical currently trades at $75.69 per share and has shown little upside over the past six months, posting a middling return of 3.4%. However, the stock is beating the S&P 500’s 5.2% decline... 
Via StockStory
Topics Stocks
News headline image
$1000 Invested In This Stock 10 Years Ago Would Be Worth This Much Today ↗
 
Via Benzinga
News headline image
While growth is established for GLOBUS MEDICAL INC - A (NYSE:GMED), the stock's valuation remains reasonable. ↗
Based on Fundamental Analysis it can be said that NYSE:GMED is a growth stock which is not overvalued. 
Via Chartmill
< Previous 1 2 3 4 5 6 7 8 9
...
12 13 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

More ways to get to us

Lethbridge Herald Facebook Facebook
Lethbridge Herald Twitter Twitter
Lethbridge Herald YouTube YouTube

About Us

Contact the Lethbridge Herald

504 - 7th Street South
Lethbridge, AB T1J 3Z7

[P] (403) 328-4411
[F] (403)328-4536

Print Advertising: (403) 328-4410
National Advertising: (403) 380-7585
Online Advertising: (403) 380-7585
Classifieds: (403) 328-4433

© 1996-2017 The Lethbridge Herald, A Division of Continental Newspapers Canada Ltd.